03:39 PM EST - Cannasat Therapeutics Inc. : said its net loss was $1.75 million for the year ended December 31, 2009. In addition, effective March 3, 2010, the corporation granted stock options to buy 425,000 shares in the capital of the corporation. The stock options will be granted to a director, an officers and an employee at an exercise price equal to $0.10 per share and with an expiry of five years. Cannasat Therapeutics Inc.
shares V.CTH are trading up $0.015 at $0.10.
